{
    "startDate": "2020-08-01",
    "endDate": "2021-04-30",
    "year": "2021",
    "quarter": "Q3",
    "symbol": "RFL",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents, beginning of period",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 4679000
            },
            {
                "label": "Trade accounts receivable, net of allowance for doubtful accounts of $183 and $218 at April 30, 2021 and July 31, 2020, respectively",
                "concept": "ReceivablesNetCurrent",
                "unit": "usd",
                "value": 248000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 625000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 6032000
            },
            {
                "label": "Total",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 43591000
            },
            {
                "label": "Due from RP Finance LLC",
                "concept": "DueFromRelatedPartiesNoncurrent",
                "unit": "usd",
                "value": 3750000
            },
            {
                "label": "Investments \u2013 Rafael Pharmaceuticals",
                "concept": "LongTermInvestments",
                "unit": "usd",
                "value": 79141000
            },
            {
                "label": "Deferred income tax assets, net",
                "concept": "DeferredIncomeTaxAssetsNet",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 1482000
            },
            {
                "label": "Total current assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 146208000
            },
            {
                "label": "Trade accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 753000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 861000
            },
            {
                "label": "Other current liabilities",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 235000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 4909000
            },
            {
                "label": "Deferred income tax liabilities, net",
                "concept": "DeferredIncomeTaxLiabilitiesNet",
                "unit": "usd",
                "value": 9000
            },
            {
                "label": "Other liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 33000
            },
            {
                "label": "Total current liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 4951000
            },
            {
                "label": "Commitments and Contingencies Disclosure [Abstract]",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Class A common stock, $0.01 par value; 35,000,000 shares authorized, 787,163 shares issued and outstanding as of April 30, 2021 and July 31, 2020, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 8000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 151258000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -28419000
            },
            {
                "label": "Accumulated other comprehensive income related to foreign currency translation adjustment",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 3766000
            },
            {
                "label": "Total equity attributable to Rafael Holdings, Inc.",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 126771000
            },
            {
                "label": "Noncontrolling interests",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 14486000
            },
            {
                "label": "TOTAL EQUITY",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 141257000
            },
            {
                "label": "TOTAL LIABILITIES AND EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 146208000
            }
        ],
        "cf": [
            {
                "label": "Consolidated net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -12318000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 1079000
            },
            {
                "label": "Deferred income taxes",
                "concept": "DeferredIncomeTaxesAndTaxCredits",
                "unit": "usd",
                "value": 15000
            },
            {
                "label": "Impairment of investments - Other Pharmaceuticals",
                "concept": "ImpairmentOfInvestments",
                "unit": "usd",
                "value": 724000
            },
            {
                "label": "Impairment - Altira",
                "concept": "AssetImpairmentCharges",
                "unit": "usd",
                "value": 7000000
            },
            {
                "label": "Equity in earnings of RP Finance",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 288000
            },
            {
                "label": "(Recovery of) provision for doubtful accounts",
                "concept": "ProvisionForDoubtfulAccounts",
                "unit": "usd",
                "value": -183000
            },
            {
                "label": "Number of Options, Outstanding, Beginning balance",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 1023000
            },
            {
                "label": "Amortization of debt discount",
                "concept": "AmortizationOfDebtDiscountPremium",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Gain on sale of building",
                "concept": "GainLossOnSaleOfProperties",
                "unit": "usd",
                "value": 749000
            },
            {
                "label": "Trade accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -202000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 352000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": -98000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": -459000
            },
            {
                "label": "Other current liabilities",
                "concept": "IncreaseDecreaseInOtherCurrentLiabilities",
                "unit": "usd",
                "value": 120000
            },
            {
                "label": "Due to related parties",
                "concept": "IncreaseDecreaseInDueToRelatedParties",
                "unit": "usd",
                "value": 60000
            },
            {
                "label": "Due from Rafael Pharmaceuticals",
                "concept": "IncreaseDecreaseInDueFromRelatedParties",
                "unit": "usd",
                "value": 362000
            },
            {
                "label": "Accrued interest - related party",
                "concept": "IncreaseDecreaseInAccruedInterestReceivableNet",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -8620000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 237000
            },
            {
                "label": "Payments to fund RP Finance",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesEquity",
                "unit": "usd",
                "value": 3750000
            },
            {
                "label": "Proceeds from sale of building",
                "concept": "ProceedsFromSaleOfPropertyPlantAndEquipment",
                "unit": "usd",
                "value": 3658000
            },
            {
                "label": "Proceeds related to distribution from Hedge Funds",
                "concept": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
                "unit": "usd",
                "value": 2000000
            },
            {
                "label": "Net cash used in investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -8702000
            },
            {
                "label": "Contribution from noncontrolling interest of consolidated entity",
                "concept": "ProceedsFromMinorityShareholders",
                "unit": "usd",
                "value": 912000
            },
            {
                "label": "Proceeds from exercise of options",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 43000
            },
            {
                "label": "Proceeds from exercise of warrants",
                "concept": "ProceedsFromWarrantExercises",
                "unit": "usd",
                "value": 2000000
            },
            {
                "label": "Proceeds from issuance of shares",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 13000000
            },
            {
                "label": "Net cash provided by (used in) financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 15770000
            },
            {
                "label": "Effect of exchange rate changes on cash and cash equivalents",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalents",
                "unit": "usd",
                "value": 25000
            },
            {
                "label": "Net decrease in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": -1527000
            }
        ],
        "ic": [
            {
                "label": "Rental - Third Party",
                "concept": "OperatingLeasesIncomeStatementLeaseRevenue",
                "unit": "usd",
                "value": 654000
            },
            {
                "label": "Rental - Related Party",
                "concept": "RevenueFromRelatedParties",
                "unit": "usd",
                "value": 1570000
            },
            {
                "label": "Total revenue",
                "concept": "Revenues",
                "unit": "usd",
                "value": 3002000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 8365000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 3345000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationAndAmortization",
                "unit": "usd",
                "value": 1079000
            },
            {
                "label": "Impairment - Altira",
                "concept": "GoodwillImpairmentLoss",
                "unit": "usd",
                "value": 7000000
            },
            {
                "label": "Interest expense, net",
                "concept": "InterestIncomeExpenseNet",
                "unit": "usd",
                "value": -2000
            },
            {
                "label": "Gain on sale of building",
                "concept": "MarketableSecuritiesGainLoss",
                "unit": "usd",
                "value": 749000
            },
            {
                "label": "Impairment of investments - Other Pharmaceuticals",
                "concept": "ImpairmentOfInvestments",
                "unit": "usd",
                "value": 724000
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 13000
            },
            {
                "label": "Equity in earnings of RP Finance",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 288000
            },
            {
                "label": "Net loss attributable to noncontrolling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -154000
            },
            {
                "label": "Net loss attributable to Rafael Holdings, Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -12164000
            },
            {
                "label": "Consolidated net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -12318000
            },
            {
                "label": "Foreign currency translation adjustment",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": 4000
            },
            {
                "label": "Total comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -12314000
            },
            {
                "label": "Comprehensive loss attributable to noncontrolling interests",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -39000
            },
            {
                "label": "Total comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -12275000
            },
            {
                "label": "Loss per share",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.75
            },
            {
                "label": "Basic and diluted (in Shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 16216969
            }
        ]
    }
}